Aino Siltari

Aino Siltari is a Postdoctoral Researcher specializing in Oncology and Surgical Sciences. Her work focuses on prostate cancer, statins, androgen deprivation therapy, and biomarker development. She collaborates extensively with Finnish institutions and international researchers in pharmacology and oncology.

Her research explores the impact of lipid-lowering drugs on cancer prognosis, novel therapeutic strategies for metastatic prostate cancer, and the role of anti-inflammatory agents in survival outcomes. Key trends include clinical trial follow-ups, tumor targeting mechanisms, and biomarker analysis.

• Prostate cancer risk and treatment
• Statin effects on intraprostatic biomarkers
• Metastatic castration-resistant prostate cancer (mCRPC) therapies
• Cancer survival biomarkers (e.g., thymidine kinase 1)
• NSAIDs in oncology
• 3LS-score prognostic modeling